U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252336) titled 'A Multicenter Study of CAR-T Cells in Primary Ph+All' on Nov. 18.
Brief Summary: A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients With Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia
Intervention:
DRUG: CD19 CAR-T cells
Each subject receive CD19/CD22 CAR T-cells by intravenous infusion
Recruitment Status: RECRUITING
Sponsor: Zhejiang University
Information provided by (Responsible Party): He Huang, Zhejiang University
Published by HT Digital Content Services with...